InstalabLoading...
InstalabLoading...
The amount of muscle in your legs determines whether you can stand up from a chair without using your hands, climb a flight of stairs without pausing, and recover from a fall without losing your independence. It is one of the few body composition numbers that maps almost directly onto how long you stay mobile and how well you age.
Most people learn they have lost leg muscle only after a stumble, a slow recovery from surgery, or a doctor's note about frailty. By then, the trajectory has been building for years. This number lets you see the trajectory now, while there is still room to change it.
On a DXA (dual-energy X-ray absorptiometry) scan, your legs are scanned and the lean tissue is separated from fat and bone. The result is reported as kilograms or pounds of leg lean mass. The vast majority of that lean tissue is skeletal muscle, with smaller contributions from connective tissue, blood vessels, nerves, and fluid.
Researchers often combine arm and leg lean mass into a single value called appendicular lean mass (ALM), because both arms and legs are dominated by skeletal muscle. Most large studies and reference ranges use ALM rather than legs alone. Legs typically make up the majority of ALM, so a low leg lean mass usually drags ALM down with it, but the two are not interchangeable. Where evidence below comes from ALM rather than leg lean mass specifically, that is noted.
DXA, MRI, and CT all detected roughly a 5 to 6 percent drop in leg muscle after just two weeks of bed rest in a controlled trial, confirming that this measurement responds to real changes in muscle tissue. MRI is the most precise of the three, but DXA is the most practical for routine tracking.
Legs are the engine of daily life. They carry your weight, stabilize your balance, and burn a large share of the glucose your body produces. When leg muscle shrinks, the consequences extend far beyond strength. Mobility declines, falls become more likely, and metabolic health worsens because there is less muscle tissue to absorb sugar from the bloodstream.
Relative leg lean mass tends to hold steady until around age 65 to 75, after which it declines in both sexes. Older men carry roughly 20 to 24 percent less thigh muscle than young men, with the quadriceps showing the steepest drop. That loss is often invisible on a regular doctor's visit but is the foundation of what gets diagnosed years later as frailty or sarcopenia.
In mobility-limited older adults, total leg lean mass is one of the strongest predictors of how well someone performs on a standard physical performance battery (a short test of balance, walking, and standing up from a chair). A separate study of 70- to 79-year-olds found that smaller midthigh muscle area and more fat infiltrating the muscle both tracked poorer walking speed and slower chair stands.
Function and muscle mass move together but not identically. In one 16-week training study of resistance-trained young men, strength gains occurred with little change in lean mass, which means strength testing complements rather than replaces a body composition scan.
How muscle is distributed across your body matters as much as how much you have. In a UK Biobank analysis of more than 40,000 adults, a higher trunk-to-leg lean mass ratio (more lean tissue concentrated in the trunk relative to the legs) was associated with higher all-cause and cancer mortality, even after accounting for obesity. A separate prospective US study of about 380,000 men found a U-shaped link between predicted whole-body lean mass and all-cause death: risk fell steeply as lean mass rose to roughly 56 kg, then ticked up slightly at the highest values.
These findings come from whole-body and ratio-based metrics rather than leg lean mass alone. The signal is consistent: too little leg muscle, especially relative to the trunk, is a meaningful risk marker.
Genetic studies of about 450,000 people in the UK Biobank found that variants linked to higher appendicular lean mass were also associated with lower type 2 diabetes risk, suggesting that ALM may be protective against diabetes. In a community study of Chinese adults, higher leg mass (both lean and fat) was associated with lower fasting glucose and HbA1c, while trunk fat moved in the opposite direction.
What this means for you: leg muscle is a metabolic asset. Losing it raises the bar for staying insulin-sensitive, especially if you also gain abdominal fat.
Low appendicular lean mass is the muscle-quantity component of sarcopenia, the age-related loss of muscle that drives frailty, falls, longer hospital stays, and higher complication rates after surgery. International sarcopenia guidelines recommend confirming low muscle mass with DXA when screening tools (such as gait speed or the SARC-F questionnaire) suggest a problem. A meta-regression of randomized trials in older adults found that gains in appendicular lean mass after protein plus exercise interventions tracked with better leg strength and walking speed.
The U-shaped curve between lean mass and mortality can look confusing, because it suggests very high lean mass is also undesirable. The likely explanation is that lean mass is a phenotype, not a single dial. Very low leg lean mass reflects sarcopenia, frailty, and poor metabolic reserve. Very high values often appear in people with high overall body mass, where the absolute lean number is partly a marker of carrying more weight overall. The protective range is broad. The risky range is the bottom end, where most adults trying to optimize their health actually live.
Leg-specific cutpoints are not standardized. The published thresholds below come from appendicular lean mass studies (arms plus legs) using two different DXA systems, in mostly Caucasian adult populations. They are illustrative orientation, not a universal target. Different scanners and ethnicities yield different numbers, so compare your own results within the same lab over time.
| Tier (T-score basis) | Appendicular lean mass index, men | Appendicular lean mass index, women |
|---|---|---|
| Low (T-score about minus 1) | About 7.87 kg/m squared (Lunar DXA) | About 6.07 kg/m squared (Lunar DXA) |
| Sarcopenia threshold (T-score about minus 2) | About 6.94 kg/m squared (Lunar DXA) | About 5.30 kg/m squared (Lunar DXA) |
| FNIH-style cutpoint (ALM/BMI, Hologic) | About 0.77 kg per kg/m squared | About 0.53 kg per kg/m squared |
Source: Geelong Osteoporosis Study (Lunar DXA, men and women aged 20 to 93) and the Australian Body Composition Study (Hologic DXA, adults 18 to 88). Hologic and GE/Lunar systems are not interchangeable, and Asian and African populations often show different distributions. NHANES provides US-specific reference values stratified by sex and ethnicity.
What this means for you: rather than fixating on a single threshold, look at where your value falls within the published curves for your age, sex, and scanner type, and pay close attention to the trend across repeat scans.
A single scan tells you where you stand today. The trend tells you whether you are gaining, holding, or losing muscle, which is the actionable question. DXA can detect roughly 1 to 2 percent differences in lean and fat mass with 95 percent confidence on a well-controlled scanner, which is sensitive enough to catch real changes from training, weight loss, or aging.
Get a baseline. If you are starting a strength program, beginning a GLP-1 medication, or recovering from surgery or illness, retest in 3 to 6 months to see whether your strategy is working. After that, an annual scan is enough for most adults under 60. From your 60s on, a scan every 6 to 12 months is reasonable, because the rate of muscle loss accelerates and the cost of catching it late goes up.
If your leg or appendicular lean mass falls in the lower range for your age and sex, the next step is not to panic but to widen the picture. Pair the scan with a grip strength test, a chair-stand test, and a gait speed measurement to see whether muscle mass loss is matched by strength and function loss. If both are low, that pattern fits sarcopenia and warrants a conversation with a clinician familiar with frailty (often a geriatrician, endocrinologist, or sports medicine physician) about resistance training, protein intake, and screening for underlying drivers like low testosterone, vitamin D deficiency, or chronic inflammation.
If lean mass is low and you are on a GLP-1 agonist, recovering from surgery, or undergoing significant weight loss, the priority is preserving the muscle you have left through resistance training and adequate protein. If your trunk-to-leg ratio is high (a lot of mass concentrated in the trunk relative to the legs), that pattern flags cardiometabolic risk and is worth pairing with an ApoB (apolipoprotein B), HbA1c (a three-month average of blood sugar), and fasting insulin to map the broader picture.
Evidence-backed interventions that affect your Lean Mass (Legs) level
Lean Mass (Legs) is best interpreted alongside these tests.